Steroid contraceptive hormones may promote human papilloma virus (HPV)-DNA
integration into the host genome, may bind to specific HPV-DNA sequences within …

Hormonal contraceptive use is an identified co-factor that modifies cervical cancer risk. The
mechanisms by which sex steroid hormones affect the multi-stage natural history of human …

Background Human papillomavirus (HPV) is believed to be the most important cause of
cervical cancer. Recent studies suggest that long duration use of oral contraceptives …

To evaluate the relationship between use of oral contraceptives and risk of invasive cervical
cancer, a case‐control study involving 479 patients and 789 population controls was …

To assess the hypothesis that oral contraceptives (OCs) increase the risk of cervical
adenocarcinomas, we conducted a six-center case-control study of 124 patients with …

Invasive cervical cancer remains a leading cause of morbidity and mortality, especially
among women in the developing world where screening is either deficient or absent. Of all …

To determine cervical cancer risk associated with contemporary hormonal contraceptives,
we conducted a cohort study of women aged 15 to 49 living in Denmark from 1995 to 2014 …

Background: Oral contraception (OC) has been proclaimed by the IARC as a risk factor of
cervical cancer (CC), on prolonged use by high-risk human papillomavirus (HPV) positive …

Background: Cervical cancer is the fourth most common cancer among females globally,
with a high incidence and high mortality among females in developing countries. This …

Oncogenic human papillomavirus is the key determinant of cervical cancer, but other risk
factors interact with it to define individual risk. Among these, there is oral contraceptive (OC) …